Marc R. Gastonguay, Ph.D.

Chief Executive Officer

For the last 20 years, Marc has been applying mathematical M&S techniques to problems in clinical pharmacology and drug development across industrial, government, and academic settings. Marc provides the scientific and thought leadership for MetrumRG.

Recent publications by this scientist

Pharmacometric Dose Optimization of Buprenorphine in Neonatal Opioid Withdrawal Syndrome

June 3, 2021

Eudy-Byrne, R., Zane, N., Adeniyi-Jones, S.C., Gastonguay, M.R., Ruiz-Garcia, A., Kushal, G. and Kraft, W.K. (2021). Clinical and Translational Science. Accepted Author Manuscript. https://doi.org/10.1111/cts.13074

View More

Decision making in drug development: An opportunity for model-based knowledge integration and scenario evaluation.

April 27, 2021

Seminar presented by Marc R. Gastonguay, Ph.D., at the FDA’s Model Informed Drug Development (MIDD) Education Series, April 26, 2021 (virtual).

Download PDF

Opportunities at the Intersection of Pharmacometrics and Health Economics for Insightful Drug Development Decision Making

March 15, 2021

Marc Gastonguay, Jing Liu, Jean Lachaine, Anna G. Kondic, and Daniel Polhamus.  Presented at the American Society for Clinical Pharmacology (ASCPT) annual meeting, March 15, 2021.

Download PDF